Gene and Cell Therapy Scientists are pioneering a new era in medical treatments by developing innovative therapies that target the underlying causes of diseases at the genetic and cellular levels. These scientists utilize cutting-edge techniques like gene editing, viral vectors, and stem cell manipulation to repair, replace, or alter genetic material to treat or prevent diseases. Their work covers a wide range of conditions, from genetic disorders such as cystic fibrosis to cancers, autoimmune diseases, and even neurodegenerative diseases. By modifying the patient’s cells or genes, they aim to restore normal function or even eradicate diseases that were previously considered untreatable. In their work, gene and cell therapy scientists collaborate with multidisciplinary teams, including biologists, clinicians, and regulatory experts, to ensure that their therapies are both safe and effective. They focus on overcoming the challenges of delivering genes or engineered cells to the right locations in the body, managing immune responses, and scaling up production for clinical use. With the growing potential of personalized medicine, these scientists play a pivotal role in transforming laboratory findings into real-world, life-changing treatments. As the field progresses, gene and cell therapy scientists continue to push boundaries, offering new hope for patients suffering from chronic and genetic diseases, and reshaping the future of medicine.
Title : Principles and standards for managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : From marker to mechanism: Ligand discovery enables functional analysis of OR51E1, an ectopic olfactory receptor, in prostate cancer
Vladlen Slepak, University of Miami School of Medicine, United States
Title : Hydrogen sulfide in sepsis: From bench to bedside
Madhav Bhatia, University of Otago, New Zealand
Title : Tailored cellular environments to enable drug design
Lan Wang, Paretor LLC, United States
Title : Development of novel drug delivery pathways enabled by perillyl alcohol (NEO100), A monoterpene with multifaceted biomedical applications
Axel H Schonthal, University of Southern California, United States
Title : A NAMs-compatible mechanopharmacological model of drug penetration in the urinary bladder
Kunal Sharma, Swisss Federal Institute of Technology Lausanne, Switzerland
Title : Application of quality by design for pulmonary liposomes: Preliminary study to nano in-microparticle
Lucas Amaral Machado, University of Sao Paulo State – UNESP, Brazil
Title : Integrated Raman, SERS and computational approaches for the study of bioactive molecules in pharmaceutical chemistry
Maria Cristina Gamberini, University of Modena and Reggio Emilia, Italy
Title : The impact of metal-decorated polymeric nanodots on proton relaxivity
Paulo Cesar De Morais, Catholic University of Brasilia, Brazil
Title : Hepatotoxic botanicals-shadows of pearls
Consolato M Sergi, University of Alberta, Canada